62
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Inactivation of chromatin remodeling factors sensitizes cells to selective cytotoxic stress

, , , &
Pages 269-280 | Published online: 14 Nov 2014

References

  • KostrikenRStrathernJNKlarAJHicksJBHeffronFA site-specific endonuclease essential for mating-type switching in Saccharomyces cerevisiaeCell1983351671746313222
  • LutfiyyaLLJohnstonMTwo zinc-finger-containing repressors are responsible for glucose repression of SUC2 expressionMol Cell Biol199616479047978756637
  • SudarsanamPWinstonFThe Swi/Snf family nucleosome-remodeling complexes and transcriptional controlTrends Genet20001634535110904263
  • Perez-MartinJJohnsonADThe C-terminal domain of Sin1 interacts with the SWI-SNF complex in yeastMol Cell Biol199818415741649632800
  • KingstonRENarlikarGJATP-dependent remodeling and acetylation as regulators of chromatin fluidityGenes Dev1999132339235210500090
  • KingstonREBunkerCAImbalzanoANRepression and activation by multiprotein complexes that alter chromatin structureGenes Dev1996109059208608939
  • TurnerBMReading signals on the nucleosome with a new nomenclature for modified histonesNat Struct Mol Biol20051211011215702071
  • KornbergRDLorchYChromatin-modifying and -remodeling complexesCurr Opin Genet Dev1999914815110322131
  • AlbertsBJohnsonALewisJRaffMRobertsKWalterPMolecular Biology of the Cell4th edNew York CityGarland Science2002
  • KothandapaniAGopalakrishnanKKahaliBReismanDPatrickSMDownregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicityExp Cell Res20123181973198622721696
  • ReismanDNSciarrottaJWangWFunkhouserWKWeissmanBELoss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosisCancer Res20036356056612566296
  • FukuokaJFujiiTShihJHChromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancerClin Cancer Res2004104314432415240517
  • InoueHGiannakopoulosSParkhurstCNTarget genes of the largest human SWI/SNF complex subunit control cell growthBiochem J2011434839221118156
  • ShainAHSalariKGiacominiCPPollackJRIntegrative genomic and functional profiling of the pancreatic cancer genomeBMC Genomics20131462424041470
  • MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev20045618522915169927
  • XiaLJaafarLCashikarAFlores-RozasHIdentification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiaeCancer Res200767114111141818056469
  • KolodnerRDAlaniEMismatch repair and cancer susceptibilityCurr Opin Biotechnol199455855947765740
  • TishkoffDXBoergerALBertrandPIdentification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2Proc Natl Acad Sci U S A199794748774929207118
  • Lee TitsworthWMuradGJHohBLRahmanMFighting fire with fire: the revival of thermotherapy for gliomasAnticancer Res20143456557424510985
  • GehlJBoesgaardMPaaskeTVittrup JensenBDombernowskyPCombined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxicAnn Oncol199676876938905026
  • van KuilenburgABMaringJGEvaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patientsPharmacogenomics20131479981123651027
  • O’ShaughnessyJAFishermanJSCowanKHCombination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancerSemin Oncol19942119237939757
  • OzkanMBerkVKaplanMAGemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experienceNeoplasma201259384222103897
  • KohailHShehataSMansourOA phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanesHematol Oncol Stem Cell Ther20125424822446614
  • SiddikZHCisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene2003227265727914576837
  • Saccharomyces Genome Database [database on the Internet]Stanford, CAStanford University Available from: http://www.yeastgenome.orgAccessed 28 October, 2014
  • RichmondEPetersonCLFunctional analysis of the DNA-stimulated ATPase domain of yeast SWI2/SNF2Nucleic Acids Res199624368536928871545
  • DrorVWinstonFThe Swi/Snf chromatin remodeling complex is required for ribosomal DNA and telomeric silencing in Saccharomyces cerevisiaeMol Cell Biol2004248227823515340082
  • MalikSChaurasiaPLahudkarSUpretyBBhaumikSRRad26p regulates the occupancy of histone H2A-H2B dimer at the active genes in vivoNucleic Acids Res2012403348336322199252
  • ZhangHRichardsonDORobertsDNThe Yaf9 component of the SWR1 and NuA4 complexes is required for proper gene expression, histone H4 acetylation, and Htz1 replacement near telomeresMol Cell Biol2004249424943615485911
  • GengFCaoYLaurentBCEssential roles of Snf5p in Snf-Swi chromatin remodeling in vivoMol Cell Biol2001214311432011390659
  • StefanssonOAVillanuevaAVidalAMartiLEstellerMBRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancerEpigenetics201271225122923069641
  • MuchardtCSardetCBourachotBOnufrykCYanivMA human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrmNucleic Acids Res199523112711327739891
  • MuchardtCYanivMWhen the SWI/SNF complex remodels 1/4 the cell cycleOncogene2001203067307511420722
  • NumataMMorinagaSWatanabeTThe clinical significance of SWI/SNF complex in pancreatic cancerInt J Oncol20124240341023229642
  • HessonLBPatilVSloaneMAReassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposurePLoS Genet20139e100363623935509